Clinical Trial Update: Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating two investigational drugs for mixed hyperlipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hypertriglyceridemia

Drugs mentioned

• Investigational Drug 1
• Investigational Drug 2

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia, Hypertriglyceridemia | Phase 3 | Status: COMPLETED